NIH-funded research R01 grant

How low oxygen levels affect the body's defense against intestinal viruses

Official title: Influence of hypoxia on the antiviral functions of human intestinal epithelial cells

Funded at University of Florida · NIH-11127903 · Data updated 2026-11-12

This study is looking at how low oxygen in the intestines affects the ability of gut cells to fight off nasty viruses like rotavirus and norovirus, and it aims to help us understand how to boost our body's defenses against these infections.

More Hypoxia research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startApril 4, 2025
Project endMarch 31, 2030
Funding year2025
Award (this year)$659,313
NIH project number1R01AI185510-01A1
Project IDNIH-11127903 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are individuals, especially children and immunocompromised patients, who are at risk of severe gastrointestinal infections caused by enteric viruses.

Less likely to help

Patients with non-viral gastrointestinal issues or those not affected by enteric viruses may not benefit from this research.

What this research studies

This research investigates how low oxygen levels in the intestines influence the ability of intestinal cells to fight off viral infections, particularly from harmful viruses like rotavirus and norovirus. By using advanced technologies such as human intestinal organoids and gut-on-a-chip models, the study aims to understand the relationship between oxygen levels and the immune response of intestinal epithelial cells. The findings could provide insights into how these viruses infect the gut and how to enhance the body's defenses against them.

Why it matters

Potential benefit: If successful, this research could lead to improved treatments for viral infections in the gastrointestinal tract, particularly for vulnerable populations such as children and immunocompromised patients.

How similar studies have gone: While the specific focus on hypoxia's impact on intestinal viral infections is novel, related research has shown that understanding the gut's immune response can lead to significant advancements in treating gastrointestinal diseases.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Boulant, Steeve — University of Florida
  • Study coordinator: Boulant, Steeve

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.